blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3027063

EP3027063 - OPO GLYCERIDE COMPOSITION [Right-click to bookmark this link]
Former [2016/23]GLYCERIDE COMPOSITION
[2018/23]
StatusPatent revoked
Status updated on  09.07.2021
Database last updated on 15.11.2024
FormerThe patent has been granted
Status updated on  19.10.2018
FormerGrant of patent is intended
Status updated on  12.06.2018
FormerExamination is in progress
Status updated on  09.06.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Bunge Loders Croklaan B.V.
Hogeweg 1
1521 AZ Wormerveer / NL
[2018/33]
Former [2016/23]For all designated states
Loders Croklaan B.V.
Hogeweg 1
1521 AZ Wormerveer / NL
Inventor(s)01 / GAMBELLI, Luisa
Loders Croklaan B.V.
Hogeweg 1
NL-1521 AZ Wormerveer / NL
02 / HAPPE, Randolph
Loders Croklaan B.V.
Hogeweg 1
NL-1521 AZ Wormerveer / NL
03 / BANNI, Sebastiano
Viale Poetto 98
I-09126 Cagliari / IT
 [2016/34]
Former [2016/23]01 / GAMBELLI, Luisa
Loders Croklaan B.V.
Hogeweg 1
NL-1521 AZ Wormerveer / NL
02 / HAPPE, Randolph
Loders Croklaan B.V.
Hogeweg 1
NL-1521 AZ Wormerveer / NL
03 / BANNI, Sebastiano
Nutrisearch s.r.l.
Parco Scientifico e Tecnologico della Sardegna
Sardegna Ricerche
Edificio 5 A1, Loc. Piscinamanna
I-09010 Pula (CA) / IT
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2016/23]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date14747618.831.07.2014
[2016/23]
WO2014EP66549
Priority number, dateEP2013027518001.08.2013         Original published format: EP 13275180
[2016/23]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015014967
Date:05.02.2015
Language:EN
[2015/05]
Type: A1 Application with search report 
No.:EP3027063
Date:08.06.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 05.02.2015 takes the place of the publication of the European patent application.
[2016/23]
Type: B1 Patent specification 
No.:EP3027063
Date:21.11.2018
Language:EN
[2018/47]
Search report(s)International search report - published on:EP05.02.2015
ClassificationIPC:A23L33/10, A23L33/00, A61K31/20, A61K31/23, A61P25/28
[2018/23]
CPC:
A61K31/20 (EP,US); A61K31/231 (US); A23L33/12 (EP,US);
A23L33/15 (EP,US); A23L33/16 (EP,US); A23L33/17 (EP,US);
A23L33/40 (EP,US); A61K31/201 (EP,US); A61K31/202 (US);
A61K31/23 (EP,US); A61P25/28 (EP); A23V2002/00 (EP,US);
A23V2200/00 (EP,US) (-)
C-Set:
A23V2002/00, A23V2200/322, A23V2250/186 (EP,US)
Former IPC [2016/23]A23L33/10, A23L33/00, A61K31/20, A61K31/23
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/23]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:OPO-GLYCERIDZUSAMMENSETZUNG[2018/23]
English:OPO GLYCERIDE COMPOSITION[2018/23]
French:COMPOSITION OPO-GLYCÉRIDIQUE[2018/23]
Former [2016/23]GLYCERIDZUSAMMENSETZUNG
Former [2016/23]GLYCERIDE COMPOSITION
Former [2016/23]COMPOSITION GLYCÉRIDIQUE
Entry into regional phase27.01.2016National basic fee paid 
27.01.2016Designation fee(s) paid 
27.01.2016Examination fee paid 
Examination procedure27.01.2016Examination requested  [2016/23]
17.08.2016Amendment by applicant (claims and/or description)
12.06.2017Despatch of a communication from the examining division (Time limit: M06)
13.12.2017Reply to a communication from the examining division
13.06.2018Communication of intention to grant the patent
12.10.2018Fee for grant paid
12.10.2018Fee for publishing/printing paid
12.10.2018Receipt of the translation of the claim(s)
Opposition(s)Opponent(s)01  01.08.2019  22.08.2019  ADMISSIBLE
Frutarom Ltd.
Sagee 2000 Industrial Zone
2310001 Migdal HaEmeq / IL
Opponent's representative
De Vries & Metman
Overschiestraat 180
1062 XK Amsterdam / NL
 02  20.08.2019    ADMISSIBLE
N.V. Nederlandsch Octrooibureau
Anna van Buerenplein 21a
2595 DA The Hague / NL
Opponent's representative
Nederlandsch Octrooibureau, et al, et al
P.O. Box 29720
2502 LS The Hague / NL
 [2019/39]
Former [2019/37]
Opponent(s)01  01.08.2019    ADMISSIBLE
Frutarom Ltd.
Sagee 2000 Industrial Zone
2310001 Migdal HaEmeq / IL
Opponent's representative
De Vries & Metman
Overschiestraat 180
1062 XK Amsterdam / NL
04.09.2019Invitation to proprietor to file observations on the notice of opposition
04.12.2019Reply of patent proprietor to notice(s) of opposition
01.10.2020Cancellation of oral proceeding that was planned for 01.12.2020
01.12.2020Date of oral proceedings
18.03.2021Cancellation of oral proceeding that was planned for 27.05.2021
25.03.2021Despatch of communication that the patent will be revoked
04.04.2021Legal effect of revocation of patent [2021/32]
27.05.2021Date of oral proceedings
Fees paidRenewal fee
27.07.2016Renewal fee patent year 03
27.07.2017Renewal fee patent year 04
27.07.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.07.2014
AL21.11.2018
AT21.11.2018
CY21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
MK21.11.2018
MT21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
IE31.07.2019
LU31.07.2019
[2022/31]
Former [2021/34]HU31.07.2014
AL21.11.2018
AT21.11.2018
CY21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
MT21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
IE31.07.2019
LU31.07.2019
Former [2021/32]HU31.07.2014
AL21.11.2018
AT21.11.2018
CY21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
IE31.07.2019
LU31.07.2019
Former [2021/26]AL21.11.2018
AT21.11.2018
CY21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
IE31.07.2019
LU31.07.2019
Former [2020/36]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
IE31.07.2019
LU31.07.2019
Former [2020/27]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
LU31.07.2019
Former [2020/17]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
TR21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
Former [2020/14]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
MC21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
Former [2019/50]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SI21.11.2018
SK21.11.2018
SM21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
Former [2019/40]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SK21.11.2018
SM21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
Former [2019/37]AL21.11.2018
AT21.11.2018
CZ21.11.2018
EE21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
PL21.11.2018
RO21.11.2018
RS21.11.2018
SM21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
Former [2019/35]AL21.11.2018
AT21.11.2018
CZ21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
PL21.11.2018
RS21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
Former [2019/34]AL21.11.2018
AT21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
IT21.11.2018
LT21.11.2018
LV21.11.2018
RS21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
Former [2019/26]AL21.11.2018
AT21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RS21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
PT21.03.2019
Former [2019/25]AT21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
RS21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/24]AT21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
BG21.02.2019
NO21.02.2019
GR22.02.2019
IS21.03.2019
Former [2019/23]AT21.11.2018
ES21.11.2018
FI21.11.2018
HR21.11.2018
LT21.11.2018
LV21.11.2018
BG21.02.2019
NO21.02.2019
IS21.03.2019
Former [2019/22]FI21.11.2018
LT21.11.2018
BG21.02.2019
NO21.02.2019
IS21.03.2019
Former [2019/21]FI21.11.2018
LT21.11.2018
NO21.02.2019
IS21.03.2019
Former [2019/20]LT21.11.2018
NO21.02.2019
Cited inInternational search[X]WO2005037373  (ENZYMOTEC LTD [IL], et al) [X] 1-6,10-15 * page 9, line 5 - page 10, line 16 * * page 13, line 19 - line 21; examples 1-17; claims 1-6,11-15 *;
 [X]WO2005051091  (ENZYMOTEC LTD [IL], et al) [X] 1-6,10-15 * page 1, paragraph triglycerides; claims 1,16,28-30,36-39 * * page 13, line 6 - line 19 * * page 16, line 10 - page 17, line 20 * * page 20, line 14 - line 17 * * page 23, line 25 - page 24, line 5 * * page 26, line 9 - line 16; tables 5-6 * * page 32, line 15 - line 24 *;
 [AD]WO2007029018  (LODERS CROKLAAN BV [NL], et al) [AD] 1-15* the whole document *;
 [X]WO2009057121  (ENZYMOTEC LTD [IL], et al) [X] 1-3,10-15 * claims 1,32-37,41,47 *;
 [X]  - CARLA TECELÃO ET AL, "Production of human milk fat substitutes enriched in omega-3 polyunsaturated fatty acids using immobilized commercial lipases and Candida parapsilosis lipase/acyltransferase", JOURNAL OF MOLECULAR CATALYSIS. B, ENZYMATIC, ELSEVIER, AMSTERDAM, NL, vol. 65, no. 1-4, doi:10.1016/J.MOLCATB.2010.01.026, ISSN 1381-1177, (20100801), pages 122 - 127, (20100201), XP002687978 [X] 1-6,10-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/J.MOLCATB.2010.01.026
 [A]  - NE E AHÍN ET AL, "Human Milk Fat Substitutes Containing Omega-3 Fatty Acids", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 54, no. 10, doi:10.1021/JF053103F, ISSN 0021-8561, (20060517), pages 3717 - 3722, (20060412), XP002687979 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/JF053103F
Examination   - TABATA H ET AL, "Incorporation of plasma palmitate into the brain of the rat during development", DEVELOPMENTAL BRAIN RESEARCH, ELSEVIER SCIENCE BV, AMSTERDAM, NL, vol. 29, no. 1, doi:10.1016/0165-3806(86)90076-3, ISSN 0165-3806, (19860901), pages 1 - 8, (19860901), XP024532253

DOI:   http://dx.doi.org/10.1016/0165-3806(86)90076-3
    - Sheila M. Innis ET AL, "Dietary triacyglycerols rich in sn-2 palmitate alter post-prandial lipoprotein and unesterified fatty acids in term infants", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS., EDINBURGH, (20130901), vol. 89, no. 4, doi:10.1016/j.plefa.2013.03.003, ISSN 0952-3278, pages 145 - 151, XP055287108

DOI:   http://dx.doi.org/10.1016/j.plefa.2013.03.003
    - Fabiana Bar-Yoseph ET AL, "Review of sn-2 palmitate oil implications for infant health", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS., EDINBURGH, (20130901), vol. 89, no. 4, doi:10.1016/j.plefa.2013.03.002, ISSN 0952-3278, pages 139 - 143, XP055238040

DOI:   http://dx.doi.org/10.1016/j.plefa.2013.03.002
    - D.J Sanders ET AL, "The absorption, distribution and excretion of 1- and 2-[14C]palmitoyl triacyglycerols in the rat", FOOD AND CHEMICAL TOXICOLOGY., GB, (20010701), vol. 39, no. 7, doi:10.1016/S0278-6915(01)00017-5, ISSN 0278-6915, pages 709 - 716, XP055377411

DOI:   http://dx.doi.org/10.1016/S0278-6915(01)00017-5
OppositionWO2004100943
 WO2005036987
 WO2005051091
 WO2007029018
 WO2009057121
 WO2015014967
 EP0209327
 WO2005037373
    - BAR-YOSEPH et al., "Review of sn-2 palmitate oil implications for infant health", Science Direct, vol. 89, no. 4, (20130327), pages 139 - 143, XP055238040

DOI:   http://dx.doi.org/10.1016/j.plefa.2013.03.002
    - RUXTON et al., "The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence", The British Dietetic Association Ltd 2004 J Hum Nutr Dietet, (20040000), vol. 17, pages 449 - 459, XP055636169

DOI:   http://dx.doi.org/10.1111/j.1365-277X.2004.00552.x
    - ANONYMOUS, "BETAPOL. A BREAKTHROUGH IN INFANT FORMULA FATS", WORLD OF INGREDIENTS, (19960101), vol. 3, pages 41 - 42, XP009043320
    - LODERS CROKLAAN, "Betapol Brochure - general information", Betapol, pages 1 - 12
    - M.L. CHEN et al., "Synthesis of the structured lipid 1,3-dioleoyl-2-palmitoylglycerol from palm oil", JAOCS, (20040000), vol. 81, no. 6, doi:10.1007/s11746-006-0935-2, ISSN 0003-021X, pages 525 - 532, XP002362796

DOI:   http://dx.doi.org/10.1007/s11746-006-0935-2
    - BETAPOL, "a Breakthrough in Infant Formula Fats", The World of Ingredients, Arnhem, the Netherlands, (19960101), vol. 3, pages 41 - 42, XP009043320
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.